We are live on ! Find out more
ATI

Act Two Investors Portfolio holdings

AUM $453M
1-Year Est. Return 10.9%
This Fund
S&P 500
This Quarter Est. Return
+5.81%
1 Year Est. Return
+10.9%
3 Year Est. Return
+52.85%
5 Year Est. Return
+67.7%
10 Year Est. Return
AUM
$498M
AUM Growth
+$34.9M
Cap. Flow
+$10.4M
Cap. Flow %
2.09%
Top 10 Hldgs %
69.16%
Holding
52
New
5
Increased
22
Reduced
13
Closed
4

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$20.1M
2
GPC icon
Genuine Parts
GPC
+$17.5M
3
UNH icon
UnitedHealth
UNH
+$2.29M
4
SBUX icon
Starbucks
SBUX
+$1.13M
5
VGLT icon
Vanguard Long-Term Treasury ETF
VGLT
+$1.04M

Top Sells

Rank Stock Value
1
SYY icon
Sysco
SYY
+$18M
2
VZ icon
Verizon
VZ
+$9.39M
3
GEHC icon
GE HealthCare
GEHC
+$4.45M
4
JNJ icon
Johnson & Johnson
JNJ
+$1.32M
5
NXPI icon
NXP Semiconductors
NXPI
+$793K

Sector Composition

Rank Sector Weight
1 Technology 23.75%
2 Communication Services 17.26%
3 Healthcare 13.34%
4 Financials 13.07%
5 Consumer Discretionary 11.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
1
Microsoft
MSFT
$3.45T
$63.7M 12.79%
151,410
+473
+0.3% +$191K
GOOG icon
2
Alphabet (Google) Class C
GOOG
$4.36T
$47M 9.44%
308,753
+2,543
+0.8% +$367K
NXPI icon
3
NXP Semiconductors
NXPI
$57.8B
$36.6M 7.35%
147,702
-3,434
-2% -$793K
AMZN icon
4
Amazon
AMZN
$2.92T
$35.2M 7.07%
195,203
+3,245
+2% +$542K
TMUS icon
5
T-Mobile US
TMUS
$185B
$34.3M 6.89%
210,160
+3,616
+2% +$589K
UNH icon
6
UnitedHealth
UNH
$376B
$30.3M 6.09%
61,278
+4,510
+8% +$2.29M
V icon
7
Visa
V
$684B
$27.9M 5.61%
100,002
+1,925
+2% +$531K
NOC icon
8
Northrop Grumman
NOC
$77.1B
$24.7M 4.97%
51,656
+462
+0.9% +$213K
VGLT icon
9
Vanguard Long-Term Treasury ETF
VGLT
$10B
$24M 4.82%
405,016
+17,636
+5% +$1.04M
AZN icon
10
AstraZeneca
AZN
$263B
$20.6M 4.13%
+151,729
New +$20.1M
SCHW
11
Charles Schwab
SCHW
$183B
$19.2M 3.86%
265,662
+2,076
+0.8% +$137K
GPC icon
12
Genuine Parts
GPC
$17.1B
$18.5M 3.73%
+119,712
New +$17.5M
AAPL icon
13
Apple
AAPL
$4.54T
$16M 3.22%
93,565
-3,532
-4% -$642K
IEF icon
14
iShares 7-10 Year Treasury Bond ETF
IEF
$47.1B
$15.6M 3.13%
164,711
+6,565
+4% +$622K
BND icon
15
Vanguard Total Bond Market
BND
$157B
$15.4M 3.09%
211,885
+3,069
+1% +$223K
ENB icon
16
Enbridge
ENB
$119B
$8.32M 1.67%
230,013
+7,902
+4% +$280K
BX icon
17
Blackstone
BX
$102B
$6.73M 1.35%
51,196
-172
-0.3% -$21.5K
SYK icon
18
Stryker
SYK
$125B
$6.3M 1.27%
17,600
-84
-0.5% -$28.3K
SCHO icon
19
Schwab Short-Term US Treasury ETF
SCHO
$12.8B
$5.92M 1.19%
245,562
+7,144
+3% +$173K
JPM icon
20
JPMorgan Chase
JPM
$935B
$5.67M 1.14%
28,332
CNI icon
21
Canadian National Railway
CNI
$76.9B
$4.35M 0.87%
33,020
MCK icon
22
McKesson
MCK
$100B
$4.33M 0.87%
8,073
TMO icon
23
Thermo Fisher Scientific
TMO
$213B
$3.9M 0.78%
6,710
-940
-12% -$527K
CP icon
24
Canadian Pacific Kansas City
CP
$78.1B
$3.51M 0.71%
39,837
-2,143
-5% -$180K
GOOGL icon
25
Alphabet (Google) Class A
GOOGL
$4.36T
$2.86M 0.57%
18,934
+1,047
+6% +$150K

Similar funds

Act Two Investors's Q1 2024 Portfolio in Review

As of Q1 2024, Act Two Investors held 52 positions worth $498M, up 7.5% from $463M the previous quarter. Its ten largest holdings account for 69% of the portfolio.

Act Two Investors's Q1 2024 filing shows 5 new, 22 increased, 13 reduced and 4 closed positions. Its largest new stake was AstraZeneca: 151,729 shares worth $20.6M. The largest sale was Sysco, an estimated $18M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 24% a quarter earlier, followed by Communication Services and Healthcare.

  • Act Two Investors's largest Q1 2024 buy was AstraZeneca: 151,729 shares worth $20.6M.
  • Act Two Investors added most to UnitedHealth in Q1 2024, an estimated $2.29M increase.
  • Act Two Investors's biggest Q1 2024 reduction was GE HealthCare, cutting an estimated $4.45M.
  • Act Two Investors fully exited Sysco in Q1 2024, selling an estimated $18M.
  • Act Two Investors's ten largest holdings make up 69% of its $498M portfolio in Q1 2024.
  • Act Two Investors opened 5 new positions and closed 4 in Q1 2024.
  • Act Two Investors's portfolio value rose 7.5% quarter-over-quarter to $498M.

Based on Act Two Investors's 13F filing for Q1 2024, filed 9 May 2024.